Center Star Asset Management, LLC Editas Medicine, Inc. Call Options Transaction History

Center Star Asset Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 Apr 29, 2019	SELL	$19.43 - $26.41 $46,632 - $63,384	-2,400 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$18.19 - $31.79 $43,656 - $76,296	2,400 New	2,400 $1,000
Q3 2018 Oct 15, 2018	SELL	$27.65 - $38.39 $129,955 - $180,433	-4,700 Closed	0 $0
Q2 2018 Jul 09, 2018	BUY	$31.4 - $41.01 $84,780 - $110,727	2,700 Added 135.0%	4,700 $6,000
Q1 2018 May 01, 2018	BUY	$29.84 - $44.08 $59,680 - $88,160	2,000 New	2,000 $0

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.